Chan, DO

Chan, DO was paid $56K by Medicaid between Jan 2018 and Nov 2024, across 5 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 32% of everything it billed.

33Billing provider infoCHAN, DO
ATTLEBORO, MA 02703

33aNPI1316966393assigned 07/19/2006

33bProvider typeAnesthesiology Physician

28Total paid$56K

24GClaims1,745

24DCodes billed5

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Anesthesiology Physician providers in Massachusetts

Rank by total paid#22 of 78

Median peer was paid$5K

This provider vs. median10×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	551	$18K
2019	141	$4K
2020	285	$7K
2021	313	$6K
2022	244	$7K
2023	128	$7K
2024incomplete	83	$7K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	32%	304	300	$18K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	25%	302	282	$14K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	23%	409	395	$13K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	20%	693	669	$11K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	37	27	$444.98

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.